Why did Apollo Endosurgery, Inc. (APEN) shares slip in the Pre-marketing session?
Apollo Endosurgery, Inc. (NASDAQ: APEN), shares dropped -4.28% to 3.800 in the early morning today as the global leader in minimally invasive surgical methods announced that the X-Tack Endoscopic HeliX Tacking System had received 510(k) clearance from the U.S. Food & Drug Administration. The X-Tack is a brand new through-the-scope, a suture-based device designed specifically […]